Evaluation of Adherence to Oral Hypoglycemic Agent Prescription in Patients with Type 2 Diabetes.

Q3 Medicine Review of Diabetic Studies Pub Date : 2020-01-01 Epub Date: 2020-12-28 DOI:10.1900/RDS.2020.16.41

Mahtab Irani, Mohammad Sarafraz Yazdi, Meisam Irani, Sina Naghibi Sistani, Sahar Ghareh

{"title":"Evaluation of Adherence to Oral Hypoglycemic Agent Prescription in Patients with Type 2 Diabetes.","authors":"Mahtab Irani, Mohammad Sarafraz Yazdi, Meisam Irani, Sina Naghibi Sistani, Sahar Ghareh","doi":"10.1900/RDS.2020.16.41","DOIUrl":null,"url":null,"abstract":"Background: Diabetes is a global health problem that has affected more than 400 million people worldwide. Adherence to treatment is considered to be one of the most important and deterministic factors in the treatment of diabetes. This study investigates medication adherence and factors affecting it in patients with type 2 diabetes.Methods: This cross-sectional study investigated 136 patients with type 2 diabetes in 2018-2019. Data collection was done using a checklist that included information on personal characteristics, medication, and healthcare. The collected data were analyzed by statistical tests in SPSS 25 software.Results: 79.4% of the patients adhered to prescribed medication. Medication adherence had no significant relationship with taking other drugs, fasting blood sugar (FBS), and the daily number of hypoglycemic tablets (p ˃ 0.05). However, adherence to medication was significantly associated with age, gender, income, hemoglobin A1c, medication period, and hypoglycemia (p ˂ 0.05).Conclusions: Higher levels of adherence were observed among females aged below 60 years, with higher income, a hemoglobin A1c level below 7%, a medication period of less than 10 years, and among patients without hypoglycemia. Regarding drug type, adherence levels were lower in people taking glibenclamide.","PeriodicalId":34965,"journal":{"name":"Review of Diabetic Studies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9380091/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Review of Diabetic Studies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1900/RDS.2020.16.41","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/12/28 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

Abstract

Background: Diabetes is a global health problem that has affected more than 400 million people worldwide. Adherence to treatment is considered to be one of the most important and deterministic factors in the treatment of diabetes. This study investigates medication adherence and factors affecting it in patients with type 2 diabetes.

Methods: This cross-sectional study investigated 136 patients with type 2 diabetes in 2018-2019. Data collection was done using a checklist that included information on personal characteristics, medication, and healthcare. The collected data were analyzed by statistical tests in SPSS 25 software.

Results: 79.4% of the patients adhered to prescribed medication. Medication adherence had no significant relationship with taking other drugs, fasting blood sugar (FBS), and the daily number of hypoglycemic tablets (p ˃ 0.05). However, adherence to medication was significantly associated with age, gender, income, hemoglobin A1c, medication period, and hypoglycemia (p ˂ 0.05).

Conclusions: Higher levels of adherence were observed among females aged below 60 years, with higher income, a hemoglobin A1c level below 7%, a medication period of less than 10 years, and among patients without hypoglycemia. Regarding drug type, adherence levels were lower in people taking glibenclamide.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

2型糖尿病患者口服降糖药处方依从性的评价。

背景:糖尿病是一个全球性的健康问题，影响着全世界超过4亿人。坚持治疗被认为是糖尿病治疗中最重要和决定性的因素之一。本研究探讨2型糖尿病患者的药物依从性及其影响因素。方法:本横断面研究调查了2018-2019年136例2型糖尿病患者。数据收集使用清单完成，其中包括个人特征、药物和医疗保健信息。收集的数据在SPSS 25软件中进行统计检验。结果:79.4%的患者遵医嘱服药。服药依从性与服用其他药物、空腹血糖(FBS)、每日降糖药片数无显著关系(p > 0.05)。然而，服药依从性与年龄、性别、收入、糖化血红蛋白、服药时间和低血糖显著相关(p小于0.05)。结论:年龄在60岁以下、收入较高、糖化血红蛋白水平在7%以下、服药时间小于10年、无低血糖的女性患者中，依从性较高。就药物类型而言，服用格列本脲的人的依从性水平较低。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Review of Diabetic Studies Medicine-Internal Medicine

CiteScore

1.80

自引率

0.00%

发文量

期刊介绍： The Review of Diabetic Studies (RDS) is the society"s peer-reviewed journal published quarterly. The purpose of The RDS is to support and encourage research in biomedical diabetes-related science including areas such as endocrinology, immunology, epidemiology, genetics, cell-based research, developmental research, bioengineering and disease management.